Bicycle Therapeutics (BCYC) Treasury Shares (2018 - 2019)

Bicycle Therapeutics (BCYC) has 7 years of Treasury Shares data on file, last reported at $2.5 million in Q2 2026.

• Quarterly Treasury Shares rose 36.21% year-over-year to $2.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.5 million (up 36.21% YoY) and the FY2025 annual result came in at $1.5 million, up 129.46% from the prior year.
• Treasury Shares retreated to $2.5 million in Q2 2026, from $2.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2026 to a low of $187725.0 in Q1 2022.
• A 5-year average of $979653.9 and a median of $727594.0 in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares soared 141.08% — and 2026, when it soared 36.21%.
• Tracing BCYC's Treasury Shares over 5 years: stood at $187725.0 in 2022, then jumped by 74.11% to $326848.0 in 2023, then surged by 106.29% to $674262.0 in 2024, then soared by 129.46% to $1.5 million in 2025, then jumped by 60.05% to $2.5 million in 2026.
• The last three Treasury Shares figures came in at $2.5 million (Q2 2026), $2.8 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.